Basics Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $3.92B Activated in VL: True Average Daily Range Avg Daily Range: $0.77 | 2.30% Avg Daily Range (30 D): $0.99 | 1.87% Avg Daily Range (90 D): $1.04 | 1.72% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): 1.26M Avg Daily Volume (90 D): 1.31M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 5,551 Avg Inst. Trade: $3.35M Avg Inst. Trade (30 D): $5.92M Avg Inst. Trade (90 D): $4.87M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.65M Avg Closing Trade (30 D): $9.55M Avg Closing Trade (90 D): $10.41M Avg Closing Volume: 103.75K     News Oct 22, 2025 @ 10:40 PM Johnson Fistel Announces Class Action Lawsuit Agai... Source: Johnson Fistel, Pllp Oct 22, 2025 @ 4:00 PM LNTH INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Oct 18, 2025 @ 4:02 PM ROSEN, A RESPECTED AND LEADING FIRM, Encourages La... Source: Rosen Law Firm Oct 17, 2025 @ 2:59 PM LNTH Deadline Approaching on November 10, 2025: Ke... Source: Kessler Topaz Meltzer & Check, Llp Oct 16, 2025 @ 8:00 PM Shareholders that lost money on Lantheus Holdings,... Source: The Gross Law Firm Financials   TTM Q2 2025 Q1 2025 Basic EPS $3.93 $1.15 $1.06 Diluted EPS $3.74 $1.12 $1.02 Revenue $ 1.52B $ 378.05M $ 372.76M Gross Profit $ 969.38M $ 241.01M $ 237.7M Net Income / Loss $ 271M $ 78.76M $ 72.95M Operating Income / Loss $ 437.65M $ 87.97M $ 102.07M Cost of Revenue $ 551.27M $ 137.03M $ 135.06M Net Cash Flow $ -61.41M $ -242.95M $ 25.73M PE Ratio 15.11